John Roderick ten Bosch, SVP of Laboratory Operations at BillionToOne, Inc., filed a Form 4 on November 4, 2026, disclosing two sales of Class A Common Stock executed on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: John Roderick ten Bosch, SVP of Laboratory Operations at BillionToOne, Inc. (NASDAQ:BLLN)
  • Two sale transactions: Each involving 1,417 shares of Class A Common Stock disposed of on November 2, 2026, totaling 2,834 shares sold
  • Sale price: $113.17 per share for both transactions, as reported in the filing
  • Remaining holdings: ten Bosch beneficially owned 16,551 shares of Class A Common Stock directly following the reported transactions
  • 10b5-1 plan: Both sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026
  • Filing signed: By Thomas P. Lynch, Attorney-in-Fact, on November 4, 2026

ten Bosch's November 2026 Class A Share Sales Under 10b5-1 Plan

According to the Form 4 filed with the U.S. Securities and Exchange Commission, John Roderick ten Bosch, identified in the filing as SVP of Laboratory Operations, reported two separate dispositions of Class A Common Stock in BillionToOne, Inc. (NASDAQ:BLLN). Both transactions were recorded on November 2, 2026, each involving 1,417 shares sold at a price of $113.17 per share, for a combined total of 2,834 shares disposed of on that date.

The filing notes that both transactions were effected pursuant to a Rule 10b5-1 trading plan that the reporting person adopted on June 2, 2026. The first sale reduced ten Bosch's directly held position from 17,968 shares to 16,551 shares, as reflected across the two reported transaction lines. Following both transactions, the filing reports his direct beneficial ownership at 16,551 shares of Class A Common Stock.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Thomas P. Lynch as Attorney-in-Fact and filed on November 4, 2026. The filing also indicates, via a checked box, that the transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

What Was Disclosed

The filing disclosed two open-market sales of Class A Common Stock by ten Bosch on November 2, 2026, each of 1,417 shares at $113.17, executed under a 10b5-1 plan adopted June 2, 2026, leaving him with 16,551 directly held shares.